Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.90% | 194.18 | 1.2% | $592.16m | |
| GILD | Gilead Sciences, Inc. | -0.83% | 69.20 | 0.9% | $496.51m | |
| BIIB | Biogen Inc. | 0.72% | 324.05 | 1.3% | $476.94m | |
| CELG | Celgene Corporation | -0.47% | 69.65 | 1.2% | $474.00m | |
| ILMN | Illumina, Inc. | 0.13% | 319.93 | 3.5% | $402.89m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.08% | 345.33 | 2.6% | $297.08m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.94% | 165.11 | 1.9% | $277.86m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.89% | 118.62 | 2.0% | $201.35m | |
| A | Agilent Technologies, Inc. | 0.42% | 64.99 | 1.5% | $188.27m | |
| EXAS | Exact Sciences Corporation | 3.65% | 71.38 | 25.3% | $147.45m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.07% | 119.04 | 15.4% | $145.09m | |
| LGND | Ligand Pharmaceuticals Incorporated | 1.68% | 154.46 | 23.3% | $145.09m | |
| ECYT | Endocyte, Inc. | 0.25% | 23.67 | 2.0% | $124.13m | |
| INCY | Incyte Corporation | 2.28% | 66.51 | 2.5% | $117.76m | |
| NKTR | Nektar Therapeutics | 0.11% | 38.23 | 5.6% | $117.70m |
Company Profile
SELLAS Life Sciences Group, Inc. operates as a clinical stage biopharmaceutical company, which focuses on the development and commercialization of novel cancer immunotherapeutic for a broad range of indications. Its product galinpepimut-S, or GPS, is an immunotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, which targets the Wilms tumor 1, or WT1, protein. The company was founded on April 3, 2006 and is headquartered in New York, NY.